Patent ID: 7338975
Filing Date: 2008-03-04
Classification: C07D

Abstract:
1. A compound of Formula (I) or a stereoisomer or a pharmaceutically acceptable salt thereof, wherein: Z is —NR Q is O; wherein neither Z nor R X is —CHR bond (a) is a single or double bond; R R R with the proviso that R alternatively, R R R R R R R R R, at each occurrence, is independently selected from H, C R alternatively, two R R R R R R R alternatively, two R R R R R R R′, at each occurrence, is selected from H, C R alternatively, R R R R R R R R R R R R R R alternatively, R R R R R R R R R R R R R R alternatively, R R R R R R R R R R R R R R R R R R R R R R R R R R R R R R n is 1; l is selected from 0 and 1; m is selected from 0 and 1; p, at each occurrence, is selected from 0, 1, or 2; q, at each occurrence, is selected from 1, 2, 3, or 4; r, at each occurrence, is selected from 0, 1, 2, 3, or 4; s is selected from 0 and 1; and t is selected form 1, 2 and 3.